FACS Canto Service Agreement
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The National Cancer Institute (NCI) intends to award a sole source contract to Becton Dickinson (BD) Biosciences for a FACSCanto Service Agreement. This notice is an intent to award and not a request for quotations. Interested parties believing they can meet the requirement must submit a statement of capabilities within 10 days of publication.
Scope of Work
The contract covers the acquisition of services for the FACSCanto machine used daily by NCI's Laboratory of Cellular Oncology. The contractor will provide all labor, material, and equipment for preventive maintenance to ensure the instrument remains available and in good working condition. All maintenance services must adhere to the manufacturer's standard practices.
Contract & Timeline
- Type: Sole Source Purchase Order (Simplified Acquisition Procedures)
- Intended Awardee: Becton Dickinson (BD) Biosciences
- Authority: FAR Subpart 13.106-1(b)
- Period of Performance: February 28, 2026 – February 27, 2027
- NAICS: 811210 – Electronic and Precision Equipment Repair and Maintenance (Size Standard: $34M)
- Set-Aside: None (Sole Source)
- Response Due: February 16, 2026 (10 days from publication)
- Published: February 6, 2026
Action for Interested Parties
NCI will solicit and negotiate directly with BD Biosciences. However, interested parties may submit a statement of capabilities in writing, providing sufficient detail to demonstrate their ability to meet the requirement. The Government will use these responses to determine if a competitive procurement is feasible. If no affirmative responses are received within the 10-day period, the award will proceed to BD Biosciences. This is not a request for competitive proposals.
Additional Notes
This procurement is processed using Simplified Acquisition Procedures. There is no solicitation package available. For questions, contact Elizabeth Bulger at elizabeth.bulger@hhs.gov.